+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Injection sclerotherapy of esophageal varices using ethanolamine oleate



Injection sclerotherapy of esophageal varices using ethanolamine oleate



American Journal of Surgery 143(4): 426-431



Fifty-three patients with upper gastrointestinal bleeding and proven esophageal varices were treated by intravascular injection sclerotherapy of the varices using a mixture of ethanolamine oleate, bovine thrombin and cephalothin. An intraesophageal balloon was used to impede craniad flow during the injection. Except in three patients who failed to stop bleeding from nonvariceal lesions, sclerotherapy was 94 percent successful in controlling bleeding. The mortality rate in sclerotherapy patients with ascites was 25 percent compared with 54 to 75% reported elsewhere. There has been no rebleeding from varices after the third treatment week in patients followed up for up to 14 months.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 043419732

Download citation: RISBibTeXText

PMID: 6978620


Related references

Esophageal stricture due to endoscopic injection sclerotherapy for esophageal varices using 5 percent ethanolamine oleate. Gastroenterological Endoscopy 31(4): 831-836, 1989

Anaphylactic reaction to ethanolamine oleate injection in sclerotherapy of esophageal varices. Endoscopy 21(1): 50, 1989

Systemic dissemination of ethanolamine oleate after injection sclerotherapy for esophageal varices. Archives of Surgery 120(7): 833-836, 1985

Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology 7(5): 810-815, 1987

Studies on various esophageal lesions due to paravariceal injections of 5 percent ethanolamine oleate during endoscopic injection sclerotherapy of esophageal varices. Gastroenterological Endoscopy 28(10): 2257-2267, 1986

Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial. Hepato-Gastroenterology 34(1): 19-23, 1987

Absolute ethanol and 5% ethanolamine oleate are comparable for sclerotherapy of esophageal varices. Gastrointestinal Endoscopy 51(5): 573-576, 2000

Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate. Hepato-Gastroenterology 45(22): 1155-1158, 1998

Mechanism of the haemostatic effect of ethanolamine oleate in the injection sclerotherapy for oesophageal varices. British Journal of Surgery 74(1): 50-53, 1987

Mechanism of action of ethanolamine oleate used in injection sclerotherapy with special emphasis on the bronze varices. Journal of Gastroenterology and Hepatology 4(Suppl. 1): 173-175, 1989

Endoscopic injection sclerotherapy with ethanolamine oleate with iopamidol for esophagojejunal varices in idiopathic portal hypertension. Digestive Diseases and Sciences 54(7): 1592-1596, 2009

Complete eradication of duodenal varices after endoscopic injection sclerotherapy with ethanolamine oleate: a case report. Gastrointestinal Endoscopy 67(4): 759-762, 2008

Endoscopic sclerotherapy (ethanolamine oleate injection) for acute rectal varices bleeding in a patient with liver cirrhosis. Hepato-Gastroenterology 49(46): 941-943, 2002

Distribution of ethanolamine oleate after injection in esophageal varices. Nihon Geka Gakkai Zasshi 85(12): 1523-1527, 1984

Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices. Hepato-Gastroenterology 39(6): 546-548, 1992